Cargando…
First fluconazole-resistant Candida auris isolated from fungal otitis in Iran
BACKGROUND AND PURPOSE: Candida auris, as a new characterized pathogenic yeast, has attracted remarkable attention in the recent decade due to its rapid global emergence and multidrug resistance traits. This unique species is able to cause nosocomial outbreaks and tolerate adverse conditions; howeve...
Autores principales: | Taghizadeh Armaki, Mojtaba, Mahdavi Omran, Saeid, Kiakojuri, Keyvan, Khojasteh, Shaghayegh, Jafarzadeh, Jalal, Tavakoli, Mahin, Badali, Hamid, Haghani, Iman, Shokohi, Tahereh, Taghi Hedayati, Mohammad, Abastabar, Mahdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Society of Medical Mycology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443880/ https://www.ncbi.nlm.nih.gov/pubmed/34553098 http://dx.doi.org/10.18502/cmm.7.1.6243 |
Ejemplares similares
-
First report of rhino-orbital mucormycosis caused by Syncephalastrum racemosum in a diabetic patient with COVID-19 in Iran and review of recent literature
por: Taghizadeh Armaki, Mojtaba, et al.
Publicado: (2022) -
Effect of combination therapy with ceftizoxime and clotrimazole in the treatment of otomycosis
por: Mahdavi Omran, Saeid, et al.
Publicado: (2018) -
Role of Clotrimazole in Prevention of Recurrent Otomycosis
por: Kiakojuri, Keyvan, et al.
Publicado: (2019) -
Candida auris and COVID-19: A health threatening combination
por: Khojasteh, Shaghayegh, et al.
Publicado: (2022) -
Confirmation of fifth Candida auris clade by whole genome sequencing
por: Spruijtenburg, Bram, et al.
Publicado: (2022)